{
    "clinical_study": {
        "@rank": "15217", 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if duloxetine is effective when compared to\n      placebo in preventing recurrence of major depressive disorder in patients who have responded\n      to open-label duloxetine treatment."
        }, 
        "brief_title": "Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder", 
        "completion_date": "July 2003", 
        "condition": "Depressive Disorder", 
        "condition_browse": {
            "mesh_term": [
                "Depressive Disorder", 
                "Depression", 
                "Depressive Disorder, Major"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Signed the informed consent\n\n          -  Meet criteria for major depressive disorder without psychotic features.\n\n          -  Have a level of understanding sufficient to provide informed consent and to\n             communicate with the investigator and site personnel.\n\n          -  Have had at least one other major depressive episode prior to the one being\n             experienced at study entry.\n\n          -  You are reliable and agree to keep all appointments for clinic visits, tests and\n             procedures required by the protocol.\n\n        Exclusion Criteria:\n\n          -  You have had treatment with a drug within the last 30 days that has not received\n             regulatory approval at the time of study entry.\n\n          -  Any women who are pregnant or breast feeding.\n\n          -  If you have any serious medical illnesses other than major depressive disorder.\n\n          -  If you have previously participated in a clinical trial for duloxetine.\n\n          -  Any previous or current diagnosis of bipolar, schizophrenia, or other psychotic\n             disorders."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "May 8, 2002", 
        "id_info": {
            "nct_id": "NCT00036309", 
            "org_study_id": "4445", 
            "secondary_id": "F1J-MC-HMBC"
        }, 
        "intervention": {
            "intervention_name": "Duloxetine Hydrochloride", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Duloxetine"
        }, 
        "keyword": [
            "Major Depressive Disorder", 
            "Diagnostic and Statistical Manual of Mental Disorders Fourth Edition-defined major depressive disorder without psychotic features"
        ], 
        "lastchanged_date": "July 18, 2006", 
        "location": {
            "facility": {
                "address": {
                    "city": "Durham", 
                    "country": "United States", 
                    "state": "North Carolina"
                }, 
                "name": "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 3", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00036309"
        }, 
        "source": "Eli Lilly and Company", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Eli Lilly and Company", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2002", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2006"
    }, 
    "geocoordinates": {
        "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)": "35.994 -78.899"
    }
}